Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

354 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Prostate cancer update.
Rini BI, Small EJ. Rini BI, et al. Curr Opin Oncol. 2002 May;14(3):286-91. doi: 10.1097/00001622-200205000-00006. Curr Opin Oncol. 2002. PMID: 11981273 Review.
Technology evaluation: APC-8015, Dendreon.
Rini BI. Rini BI. Curr Opin Mol Ther. 2002 Feb;4(1):76-9. Curr Opin Mol Ther. 2002. PMID: 11883698 Review.
Allogeneic stem-cell transplantation of renal cell cancer after nonmyeloablative chemotherapy: feasibility, engraftment, and clinical results.
Rini BI, Zimmerman T, Stadler WM, Gajewski TF, Vogelzang NJ. Rini BI, et al. J Clin Oncol. 2002 Apr 15;20(8):2017-24. doi: 10.1200/JCO.2002.08.068. J Clin Oncol. 2002. PMID: 11956260 Clinical Trial.
Hormone-refractory Prostate Cancer.
Rini BI, Small EJ. Rini BI, et al. Curr Treat Options Oncol. 2002 Oct;3(5):437-46. doi: 10.1007/s11864-002-0008-1. Curr Treat Options Oncol. 2002. PMID: 12194808 Review.
Prostate-specific antigen kinetics as a measure of the biologic effect of granulocyte-macrophage colony-stimulating factor in patients with serologic progression of prostate cancer.
Rini BI, Weinberg V, Bok R, Small EJ. Rini BI, et al. J Clin Oncol. 2003 Jan 1;21(1):99-105. doi: 10.1200/JCO.2003.04.163. J Clin Oncol. 2003. PMID: 12506177 Clinical Trial.
The potential for prostate cancer immunotherapy.
Rini BI, Small EJ. Rini BI, et al. Crit Rev Oncol Hematol. 2003 Jun 27;46 Suppl:S117-25. doi: 10.1016/s1040-8428(03)00069-6. Crit Rev Oncol Hematol. 2003. PMID: 12850532 Review.
Antiandrogen withdrawal alone or in combination with ketoconazole in androgen-independent prostate cancer patients: a phase III trial (CALGB 9583).
Small EJ, Halabi S, Dawson NA, Stadler WM, Rini BI, Picus J, Gable P, Torti FM, Kaplan E, Vogelzang NJ. Small EJ, et al. Among authors: rini bi. J Clin Oncol. 2004 Mar 15;22(6):1025-33. doi: 10.1200/JCO.2004.06.037. J Clin Oncol. 2004. PMID: 15020604 Clinical Trial.
Cancer and Leukemia Group B 90206: A randomized phase III trial of interferon-alpha or interferon-alpha plus anti-vascular endothelial growth factor antibody (bevacizumab) in metastatic renal cell carcinoma.
Rini BI, Halabi S, Taylor J, Small EJ, Schilsky RL; Cancer and Leukemia Group B. Rini BI, et al. Clin Cancer Res. 2004 Apr 15;10(8):2584-6. doi: 10.1158/1078-0432.ccr-03-0605. Clin Cancer Res. 2004. PMID: 15102658 Clinical Trial.
Practice and progress in kidney cancer: methodology for novel drug development.
Rini BI, Weinberg V, Small EJ. Rini BI, et al. J Urol. 2004 Jun;171(6 Pt 1):2115-21. doi: 10.1097/01.ju.0000113728.46439.02. J Urol. 2004. PMID: 15126769 Review.
Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer.
Oh WK, Kantoff PW, Weinberg V, Jones G, Rini BI, Derynck MK, Bok R, Smith MR, Bubley GJ, Rosen RT, DiPaola RS, Small EJ. Oh WK, et al. Among authors: rini bi. J Clin Oncol. 2004 Sep 15;22(18):3705-12. doi: 10.1200/JCO.2004.10.195. Epub 2004 Aug 2. J Clin Oncol. 2004. PMID: 15289492 Clinical Trial.
354 results
Jump to page
Feedback